Closure of trading window for unaudited Financial Results for the quarter ending 31.12.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bandaram Pharma Packtech Ltd has informed BSE that its trading window will be closed from January 1, 2026, until 48 hours after the board declares the standalone and consolidated unaudited financial results for the quarter ending December 31, 2025. During this period, all designated persons, their immediate relatives, and connected persons covered under the company's insider trading code are prohibited from trading in the company's securities. The closure is a routine SEBI-mandated compliance measure to prevent insider trading ahead of the upcoming board meeting, where the Q3 FY26 results will be considered and approved.
This is a routine regulatory filing and carries no direct impact on shareholders or the stock price. Investors should watch for the upcoming board meeting date and Q3 FY26 results announcement, as actual earnings could move the stock.